NCT03493646 2024-05-28Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486Kirby InstitutePhase 2 Completed40 enrolled
NCT00528983 2019-11-08Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous LeukemiaCelgenePhase 1 Completed133 enrolled